Cargando…
Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113621/ https://www.ncbi.nlm.nih.gov/pubmed/37089937 http://dx.doi.org/10.3389/fphar.2023.1122008 |
_version_ | 1785027879928594432 |
---|---|
author | Jing, Jia Rui, Li Junyuan, Sun Jinfeng, Yang Zhihao, Hong Weiguo, Lu Zhenyu, Jia |
author_facet | Jing, Jia Rui, Li Junyuan, Sun Jinfeng, Yang Zhihao, Hong Weiguo, Lu Zhenyu, Jia |
author_sort | Jing, Jia |
collection | PubMed |
description | S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and numerous Skp2 inhibiting compounds have been identified. In this review, we would describe the structural features of Skp2, introduce the ubiquitination function of SCF(Skp2), and summarize the diverse natural and synthetic Skp2 inhibiting compounds reported to date. The IC(50) data of the Skp2 inhibitors or inhibiting compounds in various kinds of tumors at cellular levels implied that the cancer type, stage and pathological mechanisms should be taken into consideration when selecting Skp2-inhibiting compound for cancer treatment. |
format | Online Article Text |
id | pubmed-10113621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101136212023-04-20 Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review Jing, Jia Rui, Li Junyuan, Sun Jinfeng, Yang Zhihao, Hong Weiguo, Lu Zhenyu, Jia Front Pharmacol Pharmacology S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and numerous Skp2 inhibiting compounds have been identified. In this review, we would describe the structural features of Skp2, introduce the ubiquitination function of SCF(Skp2), and summarize the diverse natural and synthetic Skp2 inhibiting compounds reported to date. The IC(50) data of the Skp2 inhibitors or inhibiting compounds in various kinds of tumors at cellular levels implied that the cancer type, stage and pathological mechanisms should be taken into consideration when selecting Skp2-inhibiting compound for cancer treatment. Frontiers Media S.A. 2023-04-05 /pmc/articles/PMC10113621/ /pubmed/37089937 http://dx.doi.org/10.3389/fphar.2023.1122008 Text en Copyright © 2023 Jing, Rui, Junyuan, Jinfeng, Zhihao, Weiguo and Zhenyu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Jing, Jia Rui, Li Junyuan, Sun Jinfeng, Yang Zhihao, Hong Weiguo, Lu Zhenyu, Jia Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review |
title | Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review |
title_full | Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review |
title_fullStr | Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review |
title_full_unstemmed | Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review |
title_short | Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review |
title_sort | small-molecule compounds inhibiting s-phase kinase-associated protein 2: a review |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113621/ https://www.ncbi.nlm.nih.gov/pubmed/37089937 http://dx.doi.org/10.3389/fphar.2023.1122008 |
work_keys_str_mv | AT jingjia smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview AT ruili smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview AT junyuansun smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview AT jinfengyang smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview AT zhihaohong smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview AT weiguolu smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview AT zhenyujia smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview |